Goldline Pharmac

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1CLW01015
  • NSEID:
  • BSEID: 544759
INR
29.00
-0.6 (-2.03%)
BSENSE

Nov 20

BSE+NSE Vol: 9000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10040007,
    "name": "Goldline Pharmac",
    "stock_name": "Goldline Pharmac",
    "full_name": "Goldline Pharmaceutical Ltd",
    "name_url": "stocks-analysis/goldline-pharmac",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "29.00",
    "chg": -0.6,
    "chgp": "-2.03%",
    "dir": -1,
    "prev_price": "29.60",
    "mcapval": "28.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544759,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE1CLW01015",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": 9000,
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/goldline-pharmac-10040007-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10040007",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/goldline-pharmaceutical-10040007"
  },
  "announcements": [
    {
      "caption": "Declaration Of Un-Audited Standalone Financial Results Of The Company For The Half Year Ended September 30 2026",
      "datetime": "14-Nov-2026",
      "details": "Declaration of Un-audited Standalone Financial Results of the company for the half year ended September 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th November 2026 Pursuant To Reg 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "14-Nov-2026",
      "details": "Outcome of Board Meeting dated 14th November 2026 pursuant to Reg 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 & Submission of Un-audited Standalone Financial Results of the Company for the half year ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) For The Half Year Ended 30Th September 2026.",
      "datetime": "14-Nov-2026",
      "details": "Submission of statement of deviation and variation of the half year ended 30th september 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Declaration Of Un-Audited Standalone Financial Results Of The Company For The Half Year Ended September 30 2026

14-Nov-2026 | Source : BSE

Declaration of Un-audited Standalone Financial Results of the company for the half year ended September 30 2026

Board Meeting Outcome for Outcome Of Board Meeting Dated 14Th November 2026 Pursuant To Reg 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

14-Nov-2026 | Source : BSE

Outcome of Board Meeting dated 14th November 2026 pursuant to Reg 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 & Submission of Un-audited Standalone Financial Results of the Company for the half year ended September 30 2026.

Submission Of Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations) For The Half Year Ended 30Th September 2026.

14-Nov-2026 | Source : BSE

Submission of statement of deviation and variation of the half year ended 30th september 2026

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available